Gossamer Bio (GOSS) shares were up more than 10% in recent trading on Wednesday after UBS upgraded the biopharmaceutical company's stock to buy from neutral and lifted its price target to $9 from $1.25.
Trading volume stood at over 8.5 million shares against a daily average of about 3.2 million.
Price: 3.08, Change: +0.31, Percent Change: +11.01